Login / Signup

SAMHD1 silencing cooperates with radiotherapy to enhance anti-tumor immunity through IFI16-STING pathway in lung adenocarcinoma.

Yangyi LiYuke GaoXueping JiangYajie ChengJianguo ZhangLiexi XuXinyu LiuZhengrong HuangConghua XieYan Gong
Published in: Journal of translational medicine (2022)
T cell infiltration. Combination of SAMHD1 inhibition and radiotherapy may be a potentially therapeutic strategy for LUAD patients.
Keyphrases
  • early stage
  • end stage renal disease
  • ejection fraction
  • radiation therapy
  • newly diagnosed
  • locally advanced
  • chronic kidney disease
  • radiation induced
  • prognostic factors
  • patient reported